Gary Wang, once a pivotal figure at FTX as its CTO, recently shared revealing insights into the operations of FTX and Alameda Research. Highlighted were concerns around the financial handling, where Alameda Research seemed to have extracted more than the profit FTX generated through its fees. At a point, this discrepancy soared to a staggering $20 billion.
Gary Wang spoke in detail about Alameda Research’s operations:
The trial’s progression also brought to light SBF’s efforts to preserve Alameda’s image, which seemed to be paramount. He reassured investors about the safety of customer assets and portrayed Alameda merely as a market maker. Additionally, Wang introduced the concept of a faux insurance fund propagated by SBF.
One startling revelation was Alameda’s withdrawals surpassing FTX’s revenue. Wang showcased a database analysis where Alameda’s negative balance was a significant $200 million, overshadowing FTX’s revenue, pegged at $150 million.
While day 4 wrapped up with the testimony of Gary Wang, the trial is far from over. Upcoming sessions will further delve into Alameda’s extensive deficits and the purported misuse of customer funds.